In the afternoon of May 15, 2019, Dr. Ming-Wei Wang (Dean, School of Pharmacy, Fudan University and Director, The National Center for Drug Screening/Chinese National Compound Library) visited Novo Nordisk’s research and development (R&D) headquarters located at Copenhagen (Denmark). He was warmly received by Drs. Søren Tullin (Corporate Vice President, Discovery Biology & Technology and China R&D Affairs), Jesper Lau (Vice President, Research Chemistry) and Steffen Reedtz-Runge (Head, Structural Biology). They had lunch together and mainly discussed opportunities and intent of maintaining and strengthening bilateral and multilateral co-operations under the new corporate management. The two sides reached a common understanding in this aspect.